Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis

Published:2020-07-14 Issue:1 Volume:93 Page:481-490
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Huang Dong¹,Yu He¹,Wang Ting¹,Yang Huan¹,Yao Rong²³,Liang Zongan¹^ORCID

Affiliation:

1. Department of Respiratory and Critical Care Medicine, West China Hospital Sichuan University Chengdu Sichuan China

2. Emergency Medical Laboratory, Department of Emergency Medicine, West China Hospital Sichuan University Chengdu Sichuan China

3. Disaster Medical Center Sichuan University Chengdu Sichuan China

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.26256

Reference40 articles.

1. COVID‐19Coronavirus pandemic.https://www.worldometers.info/coronavirus/. Accessed June 10 2020.

2. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China

3. A longitudinal study on the mental health of general population during the COVID-19 epidemic in China

4. Candidate drugs against SARS-CoV-2 and COVID-19

5. Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapy

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Danshensu inhibits SARS-CoV-2 by targeting its main protease as a specific covalent inhibitor and discovery of bifunctional compounds eliciting antiviral and anti-inflammatory activity;International Journal of Biological Macromolecules;2024-02

2. Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update;Clinical Pathology;2024-01

3. Potential therapeutic landscape of COVID-19: molecular targets, repurposed drugs, and nano- and cell-based intervention;Stem Cells;2024

4. COVID-19: аn Update on the Modern Etiotropic Therapy Methods for the New Coronavirus Infection;Journal of Clinical Practice;2023-10-19

5. Accuracy and precision of fixed and random effects in meta‐analyses of randomized control trials for continuous outcomes;Research Synthesis Methods;2023-09-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3